ANI Pharmaceuticals Inc (ANIP) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $76.49 (+1.46%), Market cap $1.83B, P/E ratio 20.54, 52-week low–high $57.27 ~ $98.81.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baude
Financial statements, price targets, institutional (13F) holdings and related news for ANI Pharmaceuticals Inc are updated in real time on BlackAll Trade.
ANI Pharmaceuticals Inc trades at $76.49 (+1.46%). Real-time quotes and charts are available on BlackAll Trade.
ANI Pharmaceuticals Inc has a market cap of about $1.83B. Its P/E ratio is 20.54.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides i